Gerald Dodd
Concepts (377)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 15 | 2017 | 159 | 5.100 |
Why?
| Catheter Ablation | 30 | 2016 | 335 | 3.450 |
Why?
| Liver Neoplasms | 34 | 2012 | 640 | 2.020 |
Why?
| Liver | 30 | 2016 | 1839 | 1.950 |
Why?
| Portal Vein | 12 | 2016 | 108 | 1.890 |
Why?
| Tomography, X-Ray Computed | 51 | 2015 | 2515 | 1.640 |
Why?
| Diagnostic Imaging | 8 | 2017 | 327 | 1.210 |
Why?
| Carcinoma, Hepatocellular | 16 | 2005 | 272 | 1.190 |
Why?
| Liver Cirrhosis | 18 | 2003 | 279 | 1.110 |
Why?
| Blood Flow Velocity | 6 | 2016 | 406 | 1.060 |
Why?
| Microwaves | 6 | 2015 | 35 | 1.020 |
Why?
| Liver Circulation | 7 | 2016 | 19 | 0.980 |
Why?
| Societies, Medical | 4 | 2013 | 744 | 0.960 |
Why?
| Hepatectomy | 4 | 2016 | 212 | 0.950 |
Why?
| Models, Organizational | 3 | 2016 | 146 | 0.920 |
Why?
| Students, Medical | 2 | 2017 | 315 | 0.710 |
Why?
| Organizational Objectives | 3 | 2015 | 73 | 0.670 |
Why?
| Computer-Assisted Instruction | 2 | 2013 | 60 | 0.650 |
Why?
| Internet | 2 | 2013 | 615 | 0.600 |
Why?
| Delivery of Health Care | 2 | 2016 | 892 | 0.600 |
Why?
| Internship and Residency | 4 | 2013 | 1047 | 0.590 |
Why?
| Radiology Information Systems | 1 | 2016 | 28 | 0.520 |
Why?
| Biotechnology | 1 | 2016 | 39 | 0.510 |
Why?
| Laboratories | 1 | 2017 | 108 | 0.500 |
Why?
| Fasciola hepatica | 1 | 2015 | 4 | 0.500 |
Why?
| Contrast Media | 12 | 2015 | 393 | 0.500 |
Why?
| Fascioliasis | 1 | 2015 | 5 | 0.500 |
Why?
| Organizational Innovation | 1 | 2016 | 139 | 0.490 |
Why?
| Cattle | 8 | 2016 | 977 | 0.480 |
Why?
| Private Sector | 1 | 2015 | 50 | 0.470 |
Why?
| Personal Satisfaction | 1 | 2017 | 200 | 0.470 |
Why?
| Prostate | 1 | 2015 | 179 | 0.450 |
Why?
| Radiology Department, Hospital | 1 | 2014 | 15 | 0.440 |
Why?
| Health Care Reform | 1 | 2015 | 101 | 0.440 |
Why?
| Editorial Policies | 1 | 2014 | 48 | 0.430 |
Why?
| Biological Science Disciplines | 1 | 2013 | 16 | 0.430 |
Why?
| Curriculum | 3 | 2017 | 910 | 0.420 |
Why?
| Education, Medical | 2 | 2014 | 244 | 0.420 |
Why?
| Education, Graduate | 1 | 2013 | 34 | 0.420 |
Why?
| Hepatic Veins | 4 | 2000 | 31 | 0.420 |
Why?
| Computers, Handheld | 1 | 2013 | 23 | 0.410 |
Why?
| Program Evaluation | 2 | 2017 | 872 | 0.410 |
Why?
| Schools, Medical | 1 | 2014 | 132 | 0.410 |
Why?
| Advisory Committees | 1 | 2014 | 216 | 0.400 |
Why?
| Publishing | 1 | 2014 | 140 | 0.400 |
Why?
| Hemangioma, Cavernous | 1 | 2012 | 14 | 0.400 |
Why?
| Periodicals as Topic | 1 | 2014 | 204 | 0.370 |
Why?
| International Cooperation | 1 | 2012 | 174 | 0.370 |
Why?
| Efficiency, Organizational | 2 | 2015 | 133 | 0.360 |
Why?
| Ultrasonography | 19 | 2013 | 713 | 0.350 |
Why?
| Ultrasonography, Interventional | 5 | 2001 | 128 | 0.350 |
Why?
| Mobile Applications | 1 | 2013 | 160 | 0.350 |
Why?
| Societies, Scientific | 1 | 2010 | 45 | 0.340 |
Why?
| Research Support as Topic | 2 | 2010 | 111 | 0.340 |
Why?
| Thrombosis | 6 | 1997 | 343 | 0.340 |
Why?
| Education | 1 | 2010 | 100 | 0.330 |
Why?
| United States | 12 | 2016 | 13828 | 0.330 |
Why?
| Minimally Invasive Surgical Procedures | 3 | 2001 | 170 | 0.320 |
Why?
| Portasystemic Shunt, Transjugular Intrahepatic | 3 | 2000 | 41 | 0.320 |
Why?
| Magnetic Resonance Imaging | 14 | 2013 | 3386 | 0.320 |
Why?
| Cooperative Behavior | 1 | 2012 | 433 | 0.310 |
Why?
| Sensitivity and Specificity | 14 | 2016 | 1839 | 0.310 |
Why?
| Diverticulitis, Colonic | 2 | 1999 | 7 | 0.300 |
Why?
| Colonic Neoplasms | 3 | 2004 | 242 | 0.300 |
Why?
| Cholelithiasis | 2 | 1999 | 36 | 0.290 |
Why?
| Research | 2 | 2010 | 416 | 0.290 |
Why?
| Middle Aged | 53 | 2015 | 31091 | 0.280 |
Why?
| In Vitro Techniques | 5 | 2016 | 1085 | 0.280 |
Why?
| Cholangitis, Sclerosing | 2 | 1999 | 71 | 0.280 |
Why?
| Humans | 95 | 2017 | 129271 | 0.280 |
Why?
| Imaging, Three-Dimensional | 4 | 2016 | 529 | 0.270 |
Why?
| Hepatic Artery | 3 | 1996 | 59 | 0.270 |
Why?
| Terminology as Topic | 4 | 2014 | 203 | 0.260 |
Why?
| Cryosurgery | 2 | 2004 | 57 | 0.260 |
Why?
| Lymph Nodes | 3 | 1997 | 470 | 0.260 |
Why?
| Videoconferencing | 1 | 2006 | 64 | 0.250 |
Why?
| Lipoma | 3 | 1990 | 16 | 0.250 |
Why?
| Liver Transplantation | 6 | 1996 | 831 | 0.250 |
Why?
| Postoperative Complications | 7 | 2005 | 2473 | 0.240 |
Why?
| Neoplasms | 7 | 2014 | 2449 | 0.240 |
Why?
| Leiomyoma | 3 | 1990 | 74 | 0.240 |
Why?
| Aged | 36 | 2015 | 22032 | 0.230 |
Why?
| Electrocoagulation | 2 | 2001 | 37 | 0.230 |
Why?
| Teaching | 1 | 2006 | 214 | 0.220 |
Why?
| History, 21st Century | 2 | 2016 | 183 | 0.210 |
Why?
| Female | 56 | 2017 | 68556 | 0.210 |
Why?
| History, 20th Century | 2 | 2016 | 291 | 0.210 |
Why?
| Cholangiography | 2 | 2000 | 17 | 0.200 |
Why?
| Phantoms, Imaging | 2 | 2014 | 137 | 0.200 |
Why?
| Computer Simulation | 2 | 2010 | 939 | 0.200 |
Why?
| Perfusion | 3 | 2012 | 197 | 0.200 |
Why?
| Electric Injuries | 1 | 2001 | 2 | 0.190 |
Why?
| Forecasting | 2 | 2014 | 359 | 0.190 |
Why?
| Male | 53 | 2017 | 63517 | 0.180 |
Why?
| Ultrasonography, Doppler, Duplex | 3 | 1995 | 43 | 0.180 |
Why?
| Information Dissemination | 2 | 2014 | 205 | 0.180 |
Why?
| Animals | 14 | 2016 | 35309 | 0.180 |
Why?
| Carcinoma, Squamous Cell | 3 | 2011 | 625 | 0.180 |
Why?
| Head and Neck Neoplasms | 3 | 2011 | 543 | 0.180 |
Why?
| Cystadenocarcinoma, Papillary | 1 | 2000 | 5 | 0.170 |
Why?
| Adult | 36 | 2017 | 35497 | 0.170 |
Why?
| Iopanoic Acid | 1 | 2000 | 1 | 0.170 |
Why?
| Congresses as Topic | 2 | 2013 | 216 | 0.170 |
Why?
| Radiography, Interventional | 3 | 2014 | 105 | 0.170 |
Why?
| Radiography | 6 | 2012 | 796 | 0.170 |
Why?
| Ultrasonography, Doppler, Color | 2 | 2016 | 38 | 0.170 |
Why?
| Kidney Transplantation | 5 | 1993 | 671 | 0.160 |
Why?
| Chemoembolization, Therapeutic | 1 | 2000 | 48 | 0.160 |
Why?
| Peritoneal Neoplasms | 1 | 2000 | 87 | 0.160 |
Why?
| Equipment Design | 3 | 2016 | 513 | 0.160 |
Why?
| Liver Cirrhosis, Biliary | 1 | 1999 | 18 | 0.160 |
Why?
| Uterine Neoplasms | 2 | 1990 | 102 | 0.160 |
Why?
| Doxorubicin | 2 | 2011 | 328 | 0.160 |
Why?
| Image Processing, Computer-Assisted | 7 | 2008 | 742 | 0.140 |
Why?
| Radiography, Abdominal | 2 | 1999 | 46 | 0.140 |
Why?
| Arterial Occlusive Diseases | 2 | 1996 | 80 | 0.140 |
Why?
| Radiation Exposure | 1 | 2017 | 45 | 0.140 |
Why?
| Renal Artery Obstruction | 3 | 1995 | 29 | 0.140 |
Why?
| Intergenerational Relations | 1 | 2017 | 22 | 0.130 |
Why?
| Hemangioma | 1 | 1997 | 44 | 0.130 |
Why?
| Inventions | 1 | 2016 | 17 | 0.130 |
Why?
| Prospective Studies | 11 | 2005 | 7123 | 0.130 |
Why?
| Infarction | 1 | 1996 | 10 | 0.130 |
Why?
| Models, Anatomic | 1 | 2016 | 89 | 0.130 |
Why?
| Equipment Failure Analysis | 1 | 2016 | 131 | 0.130 |
Why?
| Ovarian Neoplasms | 3 | 1990 | 489 | 0.130 |
Why?
| Biopsy, Needle | 5 | 1996 | 189 | 0.130 |
Why?
| alpha-Fetoproteins | 1 | 1996 | 41 | 0.130 |
Why?
| Organ Size | 1 | 2016 | 446 | 0.120 |
Why?
| Portasystemic Shunt, Surgical | 1 | 1995 | 3 | 0.120 |
Why?
| Hepatic Veno-Occlusive Disease | 1 | 1995 | 14 | 0.120 |
Why?
| Treatment Outcome | 6 | 2016 | 10202 | 0.120 |
Why?
| Texas | 2 | 2013 | 228 | 0.120 |
Why?
| Awards and Prizes | 1 | 2016 | 63 | 0.120 |
Why?
| Ultrasonography, Doppler | 1 | 1995 | 118 | 0.120 |
Why?
| Program Development | 1 | 2017 | 355 | 0.110 |
Why?
| Constriction, Pathologic | 4 | 1996 | 226 | 0.110 |
Why?
| Radiology, Interventional | 1 | 2014 | 30 | 0.110 |
Why?
| Education, Medical, Undergraduate | 1 | 2017 | 175 | 0.110 |
Why?
| Ablation Techniques | 1 | 2014 | 33 | 0.110 |
Why?
| Research Design | 2 | 2014 | 1043 | 0.110 |
Why?
| Bile Duct Diseases | 1 | 1994 | 14 | 0.110 |
Why?
| Radiopharmaceuticals | 2 | 2011 | 168 | 0.110 |
Why?
| Reproducibility of Results | 4 | 2016 | 3080 | 0.110 |
Why?
| Neoplasm Invasiveness | 1 | 1995 | 483 | 0.110 |
Why?
| Time Factors | 10 | 2015 | 6543 | 0.110 |
Why?
| Angiography | 3 | 2000 | 196 | 0.110 |
Why?
| Dermoid Cyst | 2 | 1990 | 15 | 0.110 |
Why?
| Portography | 5 | 2000 | 11 | 0.110 |
Why?
| Diagnosis, Differential | 7 | 2002 | 1432 | 0.110 |
Why?
| Radio Waves | 1 | 2013 | 17 | 0.100 |
Why?
| Cysts | 1 | 1994 | 108 | 0.100 |
Why?
| Esophageal Neoplasms | 1 | 1997 | 295 | 0.100 |
Why?
| Linear Models | 2 | 2013 | 819 | 0.100 |
Why?
| Bile Ducts, Intrahepatic | 3 | 2000 | 65 | 0.100 |
Why?
| Information Services | 1 | 2013 | 47 | 0.100 |
Why?
| Social Networking | 1 | 2013 | 33 | 0.100 |
Why?
| Industry | 1 | 2013 | 62 | 0.100 |
Why?
| Thoracic Diseases | 1 | 1992 | 14 | 0.100 |
Why?
| Colorectal Neoplasms | 4 | 2009 | 752 | 0.100 |
Why?
| Planning Techniques | 1 | 2012 | 16 | 0.100 |
Why?
| Transplantation | 1 | 1992 | 31 | 0.100 |
Why?
| Lymphoproliferative Disorders | 1 | 1992 | 54 | 0.100 |
Why?
| Neoplasm Staging | 3 | 2001 | 1290 | 0.100 |
Why?
| Rhenium | 1 | 2011 | 4 | 0.100 |
Why?
| Radiation Protection | 1 | 2012 | 36 | 0.090 |
Why?
| Retrospective Studies | 15 | 2007 | 14461 | 0.090 |
Why?
| Educational Measurement | 1 | 2013 | 260 | 0.090 |
Why?
| Data Collection | 1 | 2014 | 647 | 0.090 |
Why?
| Antibiotics, Antineoplastic | 1 | 2011 | 123 | 0.090 |
Why?
| Varicose Veins | 1 | 1991 | 17 | 0.090 |
Why?
| Alberta | 1 | 2010 | 14 | 0.090 |
Why?
| Radiation Dosage | 1 | 2012 | 153 | 0.090 |
Why?
| Vascular Diseases | 2 | 2004 | 240 | 0.090 |
Why?
| Orbit | 1 | 1991 | 57 | 0.090 |
Why?
| Education, Continuing | 1 | 2010 | 39 | 0.090 |
Why?
| Liposarcoma | 1 | 1990 | 27 | 0.080 |
Why?
| Therapy, Computer-Assisted | 1 | 2010 | 60 | 0.080 |
Why?
| Forensic Medicine | 1 | 1990 | 17 | 0.080 |
Why?
| Documentation | 1 | 2012 | 184 | 0.080 |
Why?
| Hospitals, Teaching | 1 | 2010 | 113 | 0.080 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2012 | 253 | 0.080 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 77 | 0.080 |
Why?
| Diaphragm | 2 | 2007 | 42 | 0.080 |
Why?
| Combined Modality Therapy | 3 | 2011 | 1199 | 0.080 |
Why?
| ROC Curve | 2 | 2005 | 503 | 0.080 |
Why?
| Education, Medical, Continuing | 1 | 2010 | 122 | 0.080 |
Why?
| Professional-Patient Relations | 1 | 2010 | 138 | 0.080 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 1276 | 0.080 |
Why?
| Physicians | 1 | 2017 | 859 | 0.080 |
Why?
| Oxygen Radioisotopes | 1 | 2008 | 3 | 0.080 |
Why?
| Leadership | 1 | 2013 | 353 | 0.080 |
Why?
| Patient Selection | 2 | 2004 | 662 | 0.080 |
Why?
| Sigmoid Diseases | 2 | 1999 | 10 | 0.080 |
Why?
| Mesentery | 2 | 1999 | 47 | 0.070 |
Why?
| Kidney | 3 | 1993 | 1385 | 0.070 |
Why?
| Iopamidol | 4 | 1995 | 16 | 0.070 |
Why?
| Shoulder Pain | 1 | 2007 | 32 | 0.070 |
Why?
| Positron-Emission Tomography | 1 | 2008 | 286 | 0.070 |
Why?
| Computer Communication Networks | 1 | 2006 | 32 | 0.070 |
Why?
| Wounds, Gunshot | 1 | 1990 | 213 | 0.070 |
Why?
| Rats, Nude | 3 | 2011 | 27 | 0.060 |
Why?
| Colorado | 2 | 2013 | 4406 | 0.060 |
Why?
| Chills | 1 | 2005 | 2 | 0.060 |
Why?
| Clinical Trials as Topic | 3 | 2009 | 1004 | 0.060 |
Why?
| Liver Diseases | 3 | 1996 | 290 | 0.060 |
Why?
| Antineoplastic Agents | 2 | 2010 | 2054 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2015 | 1896 | 0.060 |
Why?
| Syndrome | 1 | 2005 | 339 | 0.060 |
Why?
| Colon | 2 | 2004 | 252 | 0.060 |
Why?
| Abdominal Neoplasms | 1 | 2004 | 34 | 0.050 |
Why?
| Aged, 80 and over | 6 | 2007 | 7055 | 0.050 |
Why?
| Fever | 1 | 2005 | 298 | 0.050 |
Why?
| Education, Medical, Graduate | 1 | 2007 | 438 | 0.050 |
Why?
| Models, Biological | 1 | 2010 | 1722 | 0.050 |
Why?
| Follow-Up Studies | 4 | 2005 | 4887 | 0.050 |
Why?
| Radiographic Image Enhancement | 2 | 2000 | 54 | 0.050 |
Why?
| Laser Therapy | 2 | 2003 | 131 | 0.050 |
Why?
| Predictive Value of Tests | 3 | 2000 | 1949 | 0.050 |
Why?
| Adolescent | 9 | 2004 | 20315 | 0.050 |
Why?
| Doppler Effect | 1 | 2002 | 3 | 0.050 |
Why?
| Retroperitoneal Space | 2 | 1999 | 16 | 0.050 |
Why?
| Monitoring, Intraoperative | 1 | 2002 | 47 | 0.050 |
Why?
| Stents | 2 | 1997 | 502 | 0.050 |
Why?
| Cholecystostomy | 1 | 2001 | 4 | 0.050 |
Why?
| Cholecystitis | 1 | 2001 | 23 | 0.040 |
Why?
| Suction | 1 | 2001 | 32 | 0.040 |
Why?
| Multiple Trauma | 1 | 2001 | 101 | 0.040 |
Why?
| Pelvic Neoplasms | 1 | 2000 | 19 | 0.040 |
Why?
| Cholecystography | 1 | 2000 | 2 | 0.040 |
Why?
| Cystic Duct | 1 | 2000 | 4 | 0.040 |
Why?
| Hepatic Duct, Common | 1 | 2000 | 6 | 0.040 |
Why?
| Diathermy | 1 | 2000 | 2 | 0.040 |
Why?
| Common Bile Duct | 1 | 2000 | 17 | 0.040 |
Why?
| Feasibility Studies | 2 | 2003 | 867 | 0.040 |
Why?
| Models, Animal | 2 | 2012 | 376 | 0.040 |
Why?
| Stomach | 1 | 2000 | 109 | 0.040 |
Why?
| Cholecystectomy | 1 | 2000 | 59 | 0.040 |
Why?
| Laser Coagulation | 1 | 2000 | 57 | 0.040 |
Why?
| Liver Regeneration | 1 | 1999 | 40 | 0.040 |
Why?
| Omentum | 1 | 1999 | 10 | 0.040 |
Why?
| Artifacts | 1 | 2000 | 126 | 0.040 |
Why?
| False Negative Reactions | 1 | 1999 | 53 | 0.040 |
Why?
| Image Enhancement | 1 | 2000 | 167 | 0.040 |
Why?
| Embolization, Therapeutic | 1 | 2001 | 206 | 0.040 |
Why?
| Neoplasm Transplantation | 2 | 2010 | 256 | 0.040 |
Why?
| Algorithms | 3 | 2010 | 1613 | 0.040 |
Why?
| Portal System | 2 | 1995 | 13 | 0.040 |
Why?
| Edema | 1 | 1999 | 124 | 0.040 |
Why?
| Iothalamate Meglumine | 2 | 1996 | 4 | 0.040 |
Why?
| Perioperative Care | 1 | 1999 | 151 | 0.040 |
Why?
| Neoplastic Cells, Circulating | 2 | 1996 | 70 | 0.040 |
Why?
| Analysis of Variance | 2 | 2011 | 1288 | 0.040 |
Why?
| Risk Assessment | 1 | 2007 | 3233 | 0.040 |
Why?
| Anesthesia | 1 | 1999 | 134 | 0.040 |
Why?
| Administration, Oral | 1 | 2000 | 785 | 0.030 |
Why?
| Bile Ducts, Extrahepatic | 1 | 1997 | 22 | 0.030 |
Why?
| Rats | 3 | 2011 | 5482 | 0.030 |
Why?
| Adenocarcinoma | 1 | 2004 | 898 | 0.030 |
Why?
| Intestines | 1 | 2000 | 347 | 0.030 |
Why?
| Appendix | 1 | 1997 | 27 | 0.030 |
Why?
| Punctures | 1 | 1996 | 40 | 0.030 |
Why?
| Ureteral Obstruction | 2 | 1994 | 62 | 0.030 |
Why?
| Kidney Diseases | 2 | 2004 | 382 | 0.030 |
Why?
| Ascites | 1 | 1996 | 44 | 0.030 |
Why?
| Drainage | 1 | 1996 | 164 | 0.030 |
Why?
| Colonic Polyps | 1 | 1997 | 87 | 0.030 |
Why?
| Injections, Intravenous | 2 | 2010 | 202 | 0.030 |
Why?
| Triiodobenzoic Acids | 3 | 2001 | 9 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2001 | 958 | 0.030 |
Why?
| Pulsatile Flow | 1 | 1995 | 59 | 0.030 |
Why?
| Regional Blood Flow | 2 | 2003 | 463 | 0.030 |
Why?
| Appendicitis | 1 | 1997 | 125 | 0.030 |
Why?
| Radionuclide Imaging | 2 | 2011 | 123 | 0.030 |
Why?
| Multivariate Analysis | 1 | 1999 | 1497 | 0.030 |
Why?
| Colic | 1 | 1994 | 7 | 0.030 |
Why?
| Vascular Patency | 1 | 1995 | 102 | 0.030 |
Why?
| Risk | 1 | 2017 | 854 | 0.030 |
Why?
| Peripheral Vascular Diseases | 1 | 1995 | 101 | 0.030 |
Why?
| Gastrointestinal Hemorrhage | 1 | 1995 | 121 | 0.030 |
Why?
| Systole | 1 | 1994 | 191 | 0.030 |
Why?
| Cholangiocarcinoma | 1 | 1994 | 77 | 0.030 |
Why?
| Population Surveillance | 1 | 1997 | 438 | 0.030 |
Why?
| Bile Duct Neoplasms | 1 | 1994 | 99 | 0.030 |
Why?
| Hyperthermia, Induced | 2 | 2005 | 109 | 0.030 |
Why?
| Vascular Resistance | 1 | 1994 | 370 | 0.030 |
Why?
| Recurrence | 1 | 1996 | 1005 | 0.020 |
Why?
| Hemangioendothelioma | 1 | 1992 | 15 | 0.020 |
Why?
| Pilot Projects | 1 | 2017 | 1584 | 0.020 |
Why?
| NADPH Dehydrogenase | 1 | 2012 | 8 | 0.020 |
Why?
| Nuclear Medicine | 1 | 2011 | 7 | 0.020 |
Why?
| Tromethamine | 1 | 2011 | 2 | 0.020 |
Why?
| Staining and Labeling | 1 | 2012 | 141 | 0.020 |
Why?
| Risk Factors | 4 | 2007 | 9746 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2011 | 192 | 0.020 |
Why?
| Isotope Labeling | 1 | 2011 | 74 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 1993 | 336 | 0.020 |
Why?
| Random Allocation | 1 | 2011 | 346 | 0.020 |
Why?
| Drug Synergism | 1 | 2011 | 370 | 0.020 |
Why?
| Acute Disease | 3 | 2001 | 978 | 0.020 |
Why?
| Finite Element Analysis | 1 | 2010 | 72 | 0.020 |
Why?
| Technetium Tc 99m Pentetate | 1 | 2010 | 7 | 0.020 |
Why?
| Chemotherapy, Adjuvant | 1 | 2011 | 379 | 0.020 |
Why?
| Liposomes | 1 | 2011 | 171 | 0.020 |
Why?
| Materials Testing | 1 | 2011 | 343 | 0.020 |
Why?
| Infant | 2 | 1994 | 8975 | 0.020 |
Why?
| Tissue Distribution | 1 | 2010 | 315 | 0.020 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 99 | 0.020 |
Why?
| Swine | 1 | 2011 | 760 | 0.020 |
Why?
| Child, Preschool | 2 | 1994 | 10459 | 0.020 |
Why?
| Efficiency | 1 | 2007 | 91 | 0.020 |
Why?
| Health Status Disparities | 1 | 2009 | 251 | 0.020 |
Why?
| Personnel Selection | 1 | 2007 | 71 | 0.020 |
Why?
| Glucose | 1 | 2011 | 1001 | 0.020 |
Why?
| Heart Transplantation | 1 | 1992 | 721 | 0.020 |
Why?
| Hemorrhage | 2 | 2004 | 678 | 0.020 |
Why?
| Child | 3 | 1994 | 20785 | 0.010 |
Why?
| Surveys and Questionnaires | 1 | 2017 | 5384 | 0.010 |
Why?
| Lasers | 1 | 2005 | 132 | 0.010 |
Why?
| Models, Statistical | 1 | 2008 | 623 | 0.010 |
Why?
| Medical Records | 1 | 2005 | 170 | 0.010 |
Why?
| Adrenal Gland Diseases | 1 | 2004 | 6 | 0.010 |
Why?
| Neoplasm Seeding | 1 | 2004 | 7 | 0.010 |
Why?
| Prognosis | 1 | 1992 | 3773 | 0.010 |
Why?
| Intestinal Obstruction | 1 | 2004 | 49 | 0.010 |
Why?
| Intestinal Perforation | 1 | 2004 | 45 | 0.010 |
Why?
| Ultrasonic Therapy | 1 | 2003 | 11 | 0.010 |
Why?
| Cryotherapy | 1 | 2003 | 16 | 0.010 |
Why?
| Gallbladder | 1 | 2003 | 17 | 0.010 |
Why?
| Hot Temperature | 1 | 2005 | 369 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2011 | 4057 | 0.010 |
Why?
| Necrosis | 1 | 2002 | 232 | 0.010 |
Why?
| Incidence | 1 | 2007 | 2636 | 0.010 |
Why?
| Venous Pressure | 1 | 2000 | 8 | 0.010 |
Why?
| Jejunum | 1 | 2000 | 30 | 0.010 |
Why?
| Postanesthesia Nursing | 1 | 1999 | 2 | 0.010 |
Why?
| Duodenum | 1 | 2000 | 75 | 0.010 |
Why?
| Burns | 1 | 2004 | 286 | 0.010 |
Why?
| Equipment Failure | 1 | 2000 | 105 | 0.010 |
Why?
| Peritoneal Diseases | 1 | 1999 | 4 | 0.010 |
Why?
| Single-Blind Method | 1 | 2000 | 271 | 0.010 |
Why?
| Confidence Intervals | 1 | 2000 | 316 | 0.010 |
Why?
| Ileum | 1 | 2000 | 115 | 0.010 |
Why?
| Observer Variation | 1 | 2000 | 315 | 0.010 |
Why?
| Statistics as Topic | 1 | 2000 | 307 | 0.010 |
Why?
| Contraindications | 1 | 1996 | 90 | 0.010 |
Why?
| Comorbidity | 1 | 2001 | 1544 | 0.010 |
Why?
| Hematocrit | 1 | 1996 | 93 | 0.010 |
Why?
| Abdomen | 1 | 1996 | 117 | 0.010 |
Why?
| Needles | 1 | 1996 | 57 | 0.010 |
Why?
| Pelvis | 1 | 1996 | 104 | 0.010 |
Why?
| Lymphatic Metastasis | 1 | 1996 | 320 | 0.010 |
Why?
| Heart Failure | 1 | 1988 | 2135 | 0.010 |
Why?
| Reference Values | 1 | 1997 | 793 | 0.010 |
Why?
| Injections, Intra-Arterial | 1 | 1994 | 25 | 0.010 |
Why?
| Splenic Artery | 1 | 1994 | 14 | 0.010 |
Why?
| Hemodynamics | 1 | 2000 | 1090 | 0.010 |
Why?
| Urography | 1 | 1994 | 16 | 0.010 |
Why?
| Mesenteric Artery, Superior | 1 | 1994 | 15 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1995 | 173 | 0.010 |
Why?
| False Positive Reactions | 1 | 1995 | 114 | 0.010 |
Why?
| Pentetic Acid | 1 | 1993 | 13 | 0.010 |
Why?
| Meglumine | 1 | 1993 | 14 | 0.010 |
Why?
| Osmolar Concentration | 1 | 1994 | 166 | 0.010 |
Why?
| Hemoglobins | 1 | 1996 | 339 | 0.010 |
Why?
| Gadolinium DTPA | 1 | 1993 | 51 | 0.010 |
Why?
| Blood Transfusion | 1 | 1996 | 295 | 0.010 |
Why?
| Catheterization, Peripheral | 1 | 1994 | 104 | 0.010 |
Why?
| Gadolinium | 1 | 1993 | 78 | 0.010 |
Why?
| Adenoma, Bile Duct | 1 | 1992 | 1 | 0.010 |
Why?
| Organometallic Compounds | 1 | 1993 | 106 | 0.010 |
Why?
| Drug Combinations | 1 | 1993 | 330 | 0.010 |
Why?
| Hydronephrosis | 1 | 1992 | 34 | 0.010 |
Why?
| Graft Survival | 1 | 1993 | 511 | 0.010 |
Why?
| Biopsy | 1 | 1992 | 1092 | 0.000 |
Why?
| Kidney Neoplasms | 1 | 1993 | 348 | 0.000 |
Why?
| Case-Control Studies | 1 | 1996 | 3377 | 0.000 |
Why?
|
|
Dodd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|